PET Quantification of Muscarinic Cholinergic Receptors with [N- 11C-methyl]-Benztropine and Application to Studies of Propofol-Induced Unconsciousness in Healthy Human Volunteers

Synapse

Volumn 51, Issue 2, 2004, Pages 91-101

  Xie, Guoming ^a   Gunn, Roger N ^a   Dagher, Alain ^a   Daloze, Thierry ^a   Plourde, Gilles ^a   Backman, Steven B ^a   Diksic, Mirko ^a   Fiset, Pierre ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Benztropine; Muscarinic receptor; Positron emission tomography; Propofol

Indexed keywords

1 METHYL 4 PIPERIDYL BENZILATE; 1 METHYL 4 PIPERIDYL BENZILATE C 11; MUSCARINIC RECEPTOR; PROPOFOL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL ERROR; ANESTHESIA MECHANISM; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GENERAL ANESTHESIA; HUMAN; IN VITRO STUDY; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DENSITY; UNCONSCIOUSNESS; WAKEFULNESS;

ADULT; ANALYSIS OF VARIANCE; BENZTROPINE; BLOOD PRESSURE; BRAIN; CARBON RADIOISOTOPES; DENSITOMETRY; ELECTROENCEPHALOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; PROPOFOL; RADIOACTIVITY; RECEPTORS, MUSCARINIC; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; UNCONSCIOUSNESS;

EID: 0346881214     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10292     Document Type: Article

References (42)

1. Alkire MT, Haier RJ. 2001. Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane. Br J Anaesth 86:618-626.
2. Birdsall NJ, Burgen AS, Hulme EC. 1978. The binding of agonists to brain muscarinic receptors. Mol Pharmacol 14:723-736.
3. Brocks DR. 1999. Anticholinergic drugs used in Parkinson's disease: an overlooked class of drugs from a pharmacokinetic perspective. J Pharm Pharm Sci 2:39-46.
4. Cheng G, Kendig JJ. 2000. Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABA or glycine receptors. Anesthesiology 93:1075-1084.
5. Dennison Jr RL, Anthony BL, Narayanan TK, Aronstam RS. 1987. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat. Neuropharmacology 26:1201-1205.
6. 11C-methyl]-benztropine. Synapse 5:213-223.
7. 11C-benztropine in primates. Neuropsychopharmacology 8:371-376.
8. Downie DL, Franks NP, Lieb WR. 2000. Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors. Anesthesiology 93:774-783.
9. Durieux ME. 1996. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. Anesthesiology 84:173-189.
10. Dutta S, Matsumoto Y, Muramatsu A, Matsumoto M, Fukuoka M, Ebling WF. 1998. Steady-state propofol brain:plasma and brain: blood partition coefficients and the effect-site equilibration paradox. Br J Anaesth 81:422-424.
11. Eckelman WC, Reba RC, Rzeszotarski WJ, Gibson RE, Hill T, Holman BL, Budinger T, Conklin JJ, Eng R, Grissom MP. 1984. External imaging of cerebral muscarinic acetylcholine receptors. Science 20; 223:291-293.
12. Evans AC, Marrett S, Neelin P, Collins L, Worsley K, Dai W, Milot S, Meyer E, Bub D. 1992. Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage 1:43-53.
13. Flohr H, Glade U, Motzko D. 1998. The role of the NMDA synapse in general anesthesia. Toxicol Lett 100-101:23-29.
14. Franks NP, Lieb WR. 1994. Molecular and cellular mechanisms of general anaesthesia. Nature 367:607-614.
15. 11C] scopolamine and positron emission tomography. J Cereb Blood. Flow Metab 12:147-154.
16. Gunn RN, Gunn SR, Cunningham VJ. 2001. Positron emission tomography compartmental models. J Cereb Blood Flow Metab 21:635-652.
17. Gyulai FE, Mintun MA, Firestone LL. 2001. Dose-dependent enhancement of in vivo GABA(A)-benzodiazepine receptor binding by isoflurane. Anesthesiology 95:585-593.
18. He H, McKay G, Midha KK. 1995. Phase I and II metabolites of benztropine in rat urine and bile. Xenobiotica 25:857-872.
19. Keifer JC, Baghdoyan HA, Lydic R. 1996. Pontine cholinergic mechanisms modulate the cortical electroencephalographic spindles of halothane anesthesia. Anesthesiology 84:945-954.
20. Kikuchi T, Wang Y, Sato K, Okumura F. 1998. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats. Br J Anaesth 80:644-648.
21. Koeppe RA. 1996. Tracer kinetics: principles of compartmental analysis and physiologic modeling. In: Henkin RE, editor. Nuclear medicine, vol. 1. St. Louis: Mosby Year Book. p 292-315.
22. 11C] di-hydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 16:1288-1299.
23. 11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. J Cereb Blood Flow Metab 19:1150-1163.
24. Leff P. 1995. The two-state model of receptor activation. Trends Pharmacol Sci 16:89-97.
25. 3H]pirenzepine. J Neurochem 46:274-279.
26. Lydic R, Keifer JC, Baghdoyan HA, Becker L. 1993. Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine. Anesthesiology 79:1003-1012.
27. Meuret P, Backman SB, Bonhomme V, Plourde G, Fiset P. 2000. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology 93:708-717.
28. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL. 1997. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389:385-389.
29. Mortazavi S, Thompson J, Baghdoyan HA, Lydic R. 1999. Fentanyl and morphine, but not remifentanil, inhibit acetylcholine release in pontine regions modulating arousal. Anesthesiology 90:1070-1077.
30. Pain L, Jeltsch H, Lehmann O, Lazarus C, Laalou FZ, Cassel JC. 2000. Central cholinergic depletion induced by 192 IgG-saporin alleviates the sedative effects of propofol in rats. Br J Anaesth 85:869-873.
31. Plummer GF. 1987. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 421:171-176.
32. Rampil IJ. 1998. A primer for EEG signal processing in anesthesia. Anesthesiology 89:980-1002.
33. Simons PJ, Cockshott ID, Douglas EJ, Gordon EA, Hopkins K, Rowland M. 1988. Disposition in male volunteers of a subanaesthetic intravenous dose of an oil in water emulsion of 14C-propofol. Xenobiotica 18:429-440.
34. 11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radio-ligand for PET studies of the muscarinic acetylcholine receptor. Synapse 45:31-37.
35. Snyder SH, Yamamura HI. 1977. Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34:236-239.
36. Tackley RM, Lewis GT, Prys-Roberts C, Boaden RW, Dixon J, Harvey JT. 1989. Computer controlled infusion of propofol. Br J Anaesth 62:46-53.
37. Tassonyi E, Charpantier E, Muller D, Dumont L, Bertrand D. 2002. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull 57:133-150.
38. Wang Y, Kikuchi T, Sakai M, Wu JL, Sato K, Okumura F. 2000. Age-related modifications of effects of ketamine and propofol on rat hippocampal acetylcholine release studied by in vivo brain microdialysis. Acta Anaesthesiol Scand 44:112-117.
39. Yamakura T, Bertaccini E, Trudell JR, Harris RA. 2001. Anesthetic and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol 41:23-51.
40. Yamamoto S, Kawana S, Miyamoto A, Ohshika H, Namiki A. 1999. Propofol-induced depression of cultured rat ventricular myocytes is related to the M2-acetylcholine receptor-NO-cGMP signaling pathway. Anesthesiology 91:1712-1719.
41. 11C]NMPB and PET. Synapse 39:275-287.
42. 11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. J Cereb Blood Flow Metab 18:619-631.